MPI

Ampio Pharmaceuticals names Disbrow as COO

Friday, November 30, 2012 11:45 AM

Ampio Pharmaceuticals, a Greenwood Village, Colo.-based biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, has appointed Josh Disbrow as chief operating officer.

More... »

MPI Research, Edge partner on brain hemorrhage therapies

Friday, April 6, 2012 09:57 AM

MPI Research, the world’s largest single-site preclinical CRO, and Edge Therapeutics, a hospital-focused biopharmaceutical company, will collaborate on preclinical and clinical testing of Edge's lead product candidates to advance life-saving therapies after brain hemorrhaging.

More... »

ICON, Empire Genomics partner to develop personalized medicines

Wednesday, November 9, 2011 08:02 AM

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Empire Genomics, a provider of genomic technologies that enable personalized medicine to be realized, have formed a strategic alliance.

More... »

Gemignani joins Champions Oncology

Wednesday, November 2, 2011 10:03 AM

Champions Oncology has named Gary G. Gemignani executive vice
president and chief financial officer.

More... »

Birch joins Truveris

Friday, October 7, 2011 11:11 AM

Truveris has named Bryan Birch chairman, president and CEO.

More... »

Ampio names chief business officer

Monday, August 22, 2011 12:50 PM

Ampio Pharmaceuticals has named Deborah Knobelman, Ph.D., chief business officer reporting directly to Ampio CEO, Don Wingerter.

More... »

Numira names Harrison to board of directors

Tuesday, August 16, 2011 12:31 PM

Numira Biosciences has named William M. Harrison to its board of directors.

More... »

MPI Research Opens First Indian Office

Friday, July 10, 2009 08:43 AM

MPI Research recently opened an office in Ahmedabad, India--the CRO's first location in India. Up until now, MPI has served the Indian clinical research market through its U.S. headquarters in Mattawan, Mich.

More... »

PRA Expands Service Offerings in Asia-Pacific

Monday, February 2, 2009 08:00 AM

Recognizing the growing potential for drug development in Southeast Asia, especially Japan, PRA International has entered into a strategic collaboration with two contract research organizations (CROs) in that region.

More... »

Preclinical CROs Expand Operations to Shanghai

Monday, October 27, 2008 09:36 AM

China has seen significant growth in the area of drug research and development in the past few years, and this growth will continue into the fourth quarter of 2008 with the opening of two new preclinical facilities in Shanghai.

More... »